Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved new therapies, a report indicated the largest single-year drop in U.S. cancer mortality, and more.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/u-s-cancer-mortality-rate-has-significant-single-year-drop/">The U.S. cancer mortality rate has continued to decline</a> for the 26th year in a row, according to data from the American Cancer Society report. In particular, 2016 to 2017 saw the largest single-year decline in cancer mortality at 2.2%. The report was published in&nbsp;CA: A Cancer Journal for Clinicians.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-ayvakit-for-gastrointestinal-cancer/">The FDA approved Ayvakit&trade;</a> (avapritinib) for adults with unresectable or metastatic&nbsp;gastrointestinal stromal tumor, including those with the PDGFRA D842V mutation.In 2018, <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/13-of-cancers-worldwide-were-infection-related-in-2018/">infections caused 13% of all new cancer diagnoses</a>, with more than 2.2 million new cases worldwide,&nbsp;according to a study published in&nbsp;The Lancet Global Health.A new study found that many <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/despite-guidelines-many-young-women-still-receive-unnecessary-pelvic-exams/">adolescent women continue to undergo pelvic examinations</a> and Papanicolaou tests, even though current guidelines suggest they may not be necessary.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-first-new-bladder-cancer-treatment-in-20-years/">The FDA granted approval for pembrolizumab</a>&mdash;marketed as Keytruda and manufactured by Merck&mdash;as an alternative to radical surgery in certain bladder&nbsp;cancer&nbsp;patients.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/despite-lawsuits-study-says-no-link-between-talc-power-and-ovarian-cancer/">Despite Lawsuits, Study Says No Link Between Talc Power and Ovarian Cancer</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/aspirin-curbs-colorectal-cancer-reoccurrence/">Aspirin Curbs Colorectal Cancer Reoccurrence</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/whats-the-life-expectancy-for-childhood-cancer-survivors/">What&rsquo;s the Life Expectancy for Childhood Cancer Survivors?</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/1-in-3-cancer-survivors-are-moderate-alcohol-drinkers/">1 in 3 Cancer Survivors are Moderate Alcohol Drinkers</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/overweight-and-obesity-linked-to-cancer/">Overweight and Obesity Linked to Cancer</a></li>
</ul>

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Hem/Onc Roundup: Largest Single-Year Cancer Mortality Decline, FDA Approvals, and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, the U.S. Food and Drug Administration (FDA) approved new ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe